Impact of obesity on acute complications of catheter ablation for cardiac arrhythmia.


Journal

Journal of cardiovascular electrophysiology
ISSN: 1540-8167
Titre abrégé: J Cardiovasc Electrophysiol
Pays: United States
ID NLM: 9010756

Informations de publication

Date de publication:
04 2022
Historique:
revised: 28 12 2021
received: 10 09 2021
accepted: 03 01 2022
pubmed: 5 2 2022
medline: 5 4 2022
entrez: 4 2 2022
Statut: ppublish

Résumé

The prevalence of obesity is increasing. However, data on the periprocedural complication rate of catheter ablation for arrhythmia in patients stratified by body mass index (BMI) are scarce. This study included 1000 consecutive patients (age 62.0 ± 14.4 years) undergoing catheter ablation for cardiac arrhythmia. The primary study endpoint was any periprocedural major complication (cardiac tamponade, pseudoaneurysm, arteriovenous fistula, transient ischemic attack, stroke, valve damage, myocardial infarction, or death). The mean BMI was 27.6 ± 5.1 kg/m In this study, obesity did not have a significant impact on the incidence of periprocedural complications after CA for cardiac arrhythmia.

Identifiants

pubmed: 35118743
doi: 10.1111/jce.15400
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

654-663

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

© 2022 Wiley Periodicals LLC.

Références

Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384(9945):766-781. doi:10.1016/S0140-6736(14)60460-8
Hruby A, Hu FB. The epidemiology of obesity: a big picture. Pharmacoeconomics. 2016;33(7):673-689. doi:10.1007/s40273-014-0243-x.The
Ogden CL, Carroll MD, Kit BK, Flegal M. Prevalence of childhood and adult obesity in the United States. JAMA. 2016;311(8):806-814. doi:10.1001/jama.2014.732.Prevalence
Pineda E, Sanchez-Romero LM, Brown M, et al. Forecasting future trends in obesity across Europe: the value of improving surveillance keywords BMI · Obesity · Epidemiology · Modelling · Policy. Obes Facts. 2018;11:360-371. doi:10.1159/000492115
Afshin A, Forouzanfar MH, Reitsma MB, et al., GBD 2015 Obesity Collaborators G 2015. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377(1):13-27. doi:10.1056/NEJMoa1614362
Pathak RK, Mahajan R, Lau DH, Sanders P. The implications of obesity for cardiac arrhythmia mechanisms and management. Can J Cardiol. 2015;31(2):203-210. doi:10.1016/j.cjca.2014.10.027
Glover BM, Hong KL, Dagres N, et al. Impact of body mass index on the outcome of catheter ablation of atrial fibrillation. Heart. 2018;105:244-250. doi:10.1136/heartjnl-2018-313490
Providência R, Adragão P, de Asmundis C, et al. Impact of body mass index on the outcomes of catheter ablation of atrial fibrillation: a European Observational Multicenter Study. J Am Heart Assoc. 2019;8(20):e012253. doi:10.1161/JAHA.119.012253
Ornelas-Loredo A, Kany S, Abraham V, et al. Association between obesity-mediated atrial fibrillation and therapy with sodium channel blocker antiarrhythmic drugs. JAMA. 2020;5(1):57-64. doi:10.1001/jamacardio.2019.4513
Tjeertes EEKM, Hoeks SSE, Beks, SSBJC, Valentijn TTM, Hoofwijk AAGM, Stolker RJRJ. Obesity-a risk factor for postoperative complications in general surgery? BMC Anesthesiol. 2015;15(1):1-7. doi:10.1186/s12871-015-0096-7
Glance LG, Li Y, Osler TM, Mukamel DB, Dick AW. Impact of obesity on mortality and complications in trauma patients. Ann Surg. 2014;259(3):576-581. doi:10.1097/SLA.0000000000000330
Hartrumpf M, Kuehnel R-U, Albes JM. The obesity paradox is still there: a risk analysis of over 15 000 cardiosurgical patients based on body mass index. Interact Cardiovasc Thorac Surg. 2017;25(1):18-24. doi:10.1093/icvts/ivx058
Mathew S, Saguner AM, Schenker N, et al. Catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia: a sequential approach. J Am Heart Assoc. 2019;8(5):1-13. doi:10.1161/JAHA.118.010365
R Core Team 2020. R Foundation for Statistical Computing, Vienna, Austria.
Pence BD, Woods JA. Exercise, obesity, and cutaneous wound healing: evidence from rodent and human studies. Adv Wound Care. 2014;3(1):71-79. doi:10.1089/wound.2012.0377
Nascimento AP, Costa AMA. Overweight induced by high-fat diet delays rat cutaneous wound healing. Br J Nutr. 2006;96(6):1069-1077. doi:10.1017/bjn20061955
Thelwall S, Harrington P, Sheridan E, Lamagni T. Impact of obesity on the risk of wound infection following surgery: results from a nationwide prospective multicentre cohort study in England. Clin Microbiol Infect. 2015;21(11):1008.e1-8. doi:10.1016/j.cmi.2015.07.003
Pierpont YN, Dinh TP, Salas RE, et al. Obesity and surgical wound healing: a current review. ISRN Obes. 2014;2014:638936. doi:10.1155/2014/638936
Kuck K-H, Brugada J, Fürnkranz A, et al. Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation. N Engl J Med. 2016;374(23):2235-2245. doi:10.1056/NEJMoa1602014
Packer DL, Mark DB, Robb RA, et al. Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA Randomized Clinical Trial. JAMA. 2019;321(13):1261-1274. doi:10.1001/jama.2019.0693
Donnellan E, Wazni O, Kanj M, et al. Outcomes of atrial fibrillation ablation in morbidly obese patients following bariatric surgery compared with a nonobese cohort. Circ Arrhythm Electrophysiol. 2019;12(10):e007598. doi:10.1161/CIRCEP.119.007598
Sivasambu B, Balouch MA, Zghaib T, et al. Increased rates of atrial fibrillation recurrence following pulmonary vein isolation in overweight and obese patients. J Cardiovasc Electrophysiol. 2018;29(2):239-245. doi:10.1111/jce.13388
Wan SH, Killu AM, Hodge DO, et al. Obesity does not increase complication rate of percutaneous epicardial access. J Cardiovasc Electrophysiol. 2014;25(11):1174-1179. doi:10.1111/jce.12485
Shoemaker MB, Muhammad R, Farrell M, et al. Relation of morbid obesity and female gender to risk of procedural complications in patients undergoing atrial fibrillation ablation. Am J Cardiol. 2013;111(3):368-373. doi:10.1016/j.amjcard.2012.10.013
Gessler N, Willems S, Steven D, et al. Supervised Obesity Reduction Trial for AF ablation patients: results from the SORT-AF trial. Europace. 2021;23:1548-1558. doi:10.1093/europace/euab122

Auteurs

Niklas Schenker (N)

Department of Cardiology, Asklepios Klinik St. Georg, Hamburg, Germany.

Flurina von Blumenthal (F)

Department of Cardiology, Asklepios Klinik St. Georg, Hamburg, Germany.

Samer Hakmi (S)

Department of Cardiology, Asklepios Klinik St. Georg, Hamburg, Germany.

Christine Lemes (C)

Department of Cardiology, Asklepios Klinik St. Georg, Hamburg, Germany.

Shibu Mathew (S)

Department of Cardiology, Justus-Liebig-University of Giessen, Giessen, Germany.

Laura Rottner (L)

University Heart & Vascular Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Peter Wohlmuth (P)

Proresearch, Asklepios Klinik St. Georg, Hamburg, Germany.

Bruno Reißmann (B)

University Heart & Vascular Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Andreas Rillig (A)

University Heart & Vascular Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Andreas Metzner (A)

University Heart & Vascular Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Stephan Willems (S)

Department of Cardiology, Asklepios Klinik St. Georg, Hamburg, Germany.

Feifan Ouyang (F)

University Heart & Vascular Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Karl-Heinz Kuck (KH)

LANS Medicum, Lanserhof Medical Group, Hamburg, Germany.

Tilman Maurer (T)

Department of Cardiology, Asklepios Klinik St. Georg, Hamburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH